The ELUTES Clinical Trial

Inclusion Criteria: * Patient must be eligible to undergo planned treatment of a single de novo lesion in a native coronary artery. * Patient must be an acceptable candidate for coronary artery bypass surgery. * Patient or legal guardian must have signed informed consent. * Patient agrees to return at one month for an office visit to assess cardiovascular status and at 6 months for an office visit to assess cardiovascular status and for a diagnostic angiogram. Exclusion Criteria: * Patient must be less than 18 years old. * Patient has history of bleeding diathesis or coagulopathy or will refuse blood transfusions. * Patient is simultaneously participating in another investigative interventional cardiovascular device or drug study. * Patient has known hypersensitivity or contraindication to aspirin, clopidogrel, or stainless steel, or a sensitivity to contrast dye. * Women of child bearing potential. * Patient has other medical condition that may cause non-compliance with the protocol, confound the results, or is associated with limited life expectancy. * Patient has been diagnosed with a myocardial infarction within 72 hours prior to procedure.